Evidence mapPaperPMID 41661514Full record

SynthesisJournal of behavioral medicine2026

Comparative efficacy of social support on glycemic control for type 2 diabetes in low- and middle-income countries or among minoritized groups in high-income countries: a systematic review and network meta-analysis.

Jiayao Deng, Zheng Zhu, Junping Wen, Wei Lin, Yaqian Mao, Gang Chen

Abstract readComparative StudyNetwork Meta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of behavioral medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiayao DengShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.ORCID http://orcid.org/0000-0002-0275-6034
Zheng ZhuDepartment of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University, Shanghai, China.ORCID http://orcid.org/0000-0003-1013-1947
Junping WenShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.ORCID http://orcid.org/0000-0002-5650-5281
Wei LinShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.ORCID http://orcid.org/0000-0002-0455-8752
Yaqian MaoShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.ORCID http://orcid.org/0000-0002-1836-7834
Gang ChenShengli Clinical Medical College of Fujian Medical University, Fuzhou, China. chengangfj@163.com.ORCID http://orcid.org/0000-0002-8105-2384

Funding

Fujian Provincial Clinical Research Centre for Type 2 Diabetes 2022Y2013National Key Clinical Specialty Discipline Construction Program of China 2023001
6 · The paper itself

Abstract

A systematic review and network meta-analysis was implemented to compare social support interventions for glycemic control in people with type 2 diabetes from low- and middle-income countries (LMICs) and those from racial and ethnic minoritized groups in high-income countries (HICs). MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched from inception to October 23, 2023. Randomized controlled trials were included, comparing social support intervention with any control condition or another social support intervention for treatment of people with type 2 diabetes from LMICs and those from racial and ethnic minoritized groups in HICs. The primary outcome was the mean change in hemoglobin A1c (HbA1c), presented as mean differences (MDs) and 95% confidence intervals (95% CIs) estimated by the random-­effects model. Treatment rankings were summarized as surface under the cumulative ranking curve (SUCRA) values. Network meta­-regression was done to investigate whether the results were associated with study characteristics. Subgroup analysis was done according to socioeconomic development. From 2885 publications, 25 trials (4180 participants) were included. These trials compared four categories of individual-based interventions provided by peers with diabetes, community health workers, health professionals, or health professionals assisted by trained laypersons, one family-based intervention implemented by health professionals, and usual care. The mean baseline HbA1c was 73 mmol/mol (8.8%). The mean age was 55.1 years (SD 4.8). The mean intervention duration was 7.1 months (SD 4.5). Family-based intervention implemented by health professionals (mean rank 1.0, SUCRA 99.9) was more effective than individual-based intervention by health professionals (mean rank 2.4, SUCRA 71.8) (MD -6 mmol/mol [-0.6%], 95% CI -10 mmol/mol to -2 mmol/mol [-0.9% to -0.2%]), individual-based intervention by peers (mean rank 3.3, SUCRA 53.7) (MD -8 mmol/mol [-0.7%], 95% CI -12 mmol/mol to -4 mmol/mol [-1.1% to -0.3%]), individual-based intervention by community health workers (mean ranks 3.8, SUCRA 43.9) (MD -8 mmol/mol [-0.8%], 95% CI -13 mmol/mol to -4 mmol/mol [-1.2% to -0.4%]), and individual-based intervention by health professionals assisted by trained laypersons (mean rank 4.6, SUCRA 28.3) (MD -10 mmol/mol [-0.9%], 95% CI -16 mmol/mol to -4 mmol/mol [-1.5% to -0.4%]). Network meta-­regression analyses showed that prespecified study characteristics did not have a significant effect. Subgroup analysis for socioeconomic development indicated no significant difference. Family-based interventions delivered by health professionals may improve glycemic control (low- to very-low-certainty evidence). Individual-based interventions by health professionals are likely to improve glycemic control (moderate-certainty evidence). Methodologically rigorous studies are still required.

Indexed as

Developing CountriesDiabetes Mellitus, Type 2Glycemic ControlSocial SupportDeveloped CountriesGlycated HemoglobinHumansRandomized Controlled Trials as TopicGlycated HemoglobinGlycemic controlSocial supportSystematic reviewType 2 diabetes

Identifiers

PMID41661514

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.